Read + Share
Saorin G, Mauceri M, Caligiuri I, Kamensek U, et al. Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal
doxorubicin in second-line therapy for ovarian cancer. Cancer Lett 2025;637:218128.
PMID: 41241303
|
 |
|
Saorin G, Mauceri M, Caligiuri I, Kamensek U, et al. Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal
doxorubicin in second-line therapy for ovarian cancer. Cancer Lett 2025;637:218128.
PMID: 41241303
|
|
|
|